If you developed uterine cancer, or ovarian cancer after using Dabur International's hair-straightening products for years, we strongly advise you to contact our law firm, as you may be entitled to compensation.
The lawsuits against Dabur International were filed after the Sister Study was published in the Journal of the National Cancer Institute. The study published on October 17, 2022, found that ingredients in hair relaxer products contain endocrine-disrupting and carcinogenic chemicals that can lead to the development of hormone-sensitive diseases such as:
- uterine cancer (endometrial cancer, uterine sarcoma)
- ovarian cancer (non-serous and serous tumors)
Shortly after the NIH study's initial results were published, a class action was filed against Dabur International in the Illinois federal court. The plaintiffs claim that their long-term use of chemical hair relaxer products manufactured and marketed by Dabur International caused the development of uterine cancer or ovarian cancer. Plaintiffs claim that the company failed to warn consumers that its hair straightening products, such as the ORS Olive Oil hair relaxers, contain endocrine-disrupting chemicals, potentially putting the consumers' health at risk.
Those who intend to file a toxic hair relaxer claim against Dabur International must meet the following eligibility requirements:
- they must have used Dabur International chemical hair relaxers for at least 2 - 5 years
- they must have used Dabur International hair relaxers at least four times a year
- they must have been diagnosed with uterine cancer or ovarian cancer